FDA: Another tool helping developers navigate the difficult road to approval of drugs for rare diseases
Written by Jennifer Huron on September 15, 2015
Today, the FDA released a blog post about a new tool for drug developers. The FDA writes, “With the vast majority of rare diseases still without FDA-approved treatments, we have recently released a new resource for drug developers — draft guidance document — designed to help them… Read More
